API vs IBEX

API's Piotroski F-Score of 4/9 indicates weak financial health, signaling deterioration in operational efficiency and profitability despite a strong current ratio and low debt. The absence of an Altman Z-Score raises concern about bankruptcy risk, particularly given negative ROA and inconsistent earnings. While the stock trades below its Graham Number ($7.62) and intrinsic value ($11.80), the current price of $3.83 reflects deep discounting due to persistent losses and volatile earnings. Analysts maintain a 'buy' recommendation, but the lack of consistent earnings beats and negative forward P/E suggest caution. The 52-week range ($2.52–$5.71) and recent 1W decline of 11.8% highlight high volatility.

IBEX exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial stability and operational efficiency. The stock is currently trading at $27.49, which is essentially at its Graham Number ($27.9) and significantly below its growth-based intrinsic value of $88.79. Despite a bearish technical trend and recent insider selling by the CEO, the combination of a low P/E (9.13), high ROE (33.65%), and robust earnings growth (45.6% YoY) presents a compelling value opportunity.